Mardi Dier, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 13,476 shares at $82.79 ($1.1M) on 2021-10-12, disclosed to the SEC on 2021-10-14.
Open-market sale of $1.1M RARE by CFO & Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.79 | 3,477 | $288K | 26.0% |
| 2 | $82.79 | 3,477 | $288K | 26.0% |
| 3 | $81.16 | 3,261 | $265K | 24.0% |
| 4 | $81.16 | 3,261 | $265K | 24.0% |
| Total | $82.00 avg | 13,476 | $1.1M | 100% |
| Filing → |
| MDGL | SELL | 2025-12-03 | $3.6M | — | Filing → |
| MDGL | SELL | 2025-03-12 | $167K | — | Filing → |
| MDGL | SELL | 2025-03-05 | $1.3M | — | Filing → |